<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9349">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00758550</url>
  </required_header>
  <id_info>
    <org_study_id>CM-06-17</org_study_id>
    <nct_id>NCT00758550</nct_id>
  </id_info>
  <brief_title>Visual Function After Bilateral Implantation of AcrySof® Toric</brief_title>
  <official_title>Visual Function After Bilateral Implantation of AcrySof® Toric</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <authority>China: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study was to evaluate visual function of AcrySof Toric and AcrySof
      Natural Intraocular Lenses (IOLs) following implant for replacement of cataract.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2007</start_date>
  <primary_completion_date type="Actual">June 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Uncorrected Visual Acuity (UCVA)</measure>
    <time_frame>6 Months after surgery</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Uncorrected Visual Acuity (UCVA) from surgery measured in logMAR. LogMAR is the &quot;logarithm of the minimum angle of resolution&quot;. A lower logMAR value indicates better visual acuity.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Questionnaire Results</measure>
    <time_frame>6 Months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Results of questionnaire rating the quality of distance vision without glasses or contact lenses. Measured on a scale of 0 to 6 (0 = worst, 6 = best).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Visual Function</condition>
  <arm_group>
    <arm_group_label>AcrySof Toric IOL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>AcrySof Toric Intraocular Lens (IOL)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AcrySof Natural IOL</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>AcrySof Natural Intraocular Lens (IOL)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AcrySof® Toric IOL</intervention_name>
    <description>AcrySof® Toric Intraocular Lens (IOL) implanted into the study eye following cataract extraction surgery</description>
    <arm_group_label>AcrySof Toric IOL</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AcrySof Natural</intervention_name>
    <description>AcrySof Natural Intraocular Lens (IOL) implanted into the study eye following cataract extraction surgery</description>
    <arm_group_label>AcrySof Natural IOL</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Bilateral cataracts

          -  40~80 years of age

          -  4 Days - 1 Week interval between a single patient's surgery

          -  dilated pupil size (in dim light) ≥ 4.0 mm

          -  Anticipated correction with an IOL of +10 Diopters ~ +25 Diopters

          -  0.75 - 2.0 Diopters of astigmatism preoperatively as measured by Keratometry readings

        Exclusion Criteria:

          -  Preoperative ocular pathology

          -  Previous intraocular or corneal surgery

          -  An increased risk for complications which could require vitreoretinal surgery

          -  Corneal irregularities

          -  Corneal opacities

          -  Current contact lens usage(within 6 months prior to first surgery)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Alcon Call Center</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2010</verification_date>
  <lastchanged_date>March 4, 2010</lastchanged_date>
  <firstreceived_date>September 23, 2008</firstreceived_date>
  <firstreceived_results_date>August 13, 2009</firstreceived_results_date>
  <responsible_party>
    <name_title>Benny Li, Scientific Clinical Affairs Manager</name_title>
    <organization>Alcon Research Ltd.</organization>
  </responsible_party>
  <keyword>Visual function;</keyword>
  <keyword>Refractive cylinder;</keyword>
  <keyword>AcrySof® Toric;</keyword>
  <keyword>AcrySof® Natural</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>

  <clinical_results>

    <participant_flow>
      <recruitment_details>60 cataract patients were enrolled into the study</recruitment_details>
      <pre_assignment_details>Randomized</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>AcrySof Toric IOL</title>
          <description>AcrySof Toric Intraocular Lens</description>
        </group>
        <group group_id="P2">
          <title>AcrySof Natural IOL</title>
          <description>AcrySof Natural Intraocular Lens</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>AcrySof Toric IOL</title>
          <description>AcrySof Toric Intraocular Lens</description>
        </group>
        <group group_id="B2">
          <title>AcrySof Natural IOL</title>
          <description>AcrySof Natural Intraocular Lens</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="30"/>
                <measurement group_id="B2" value="30"/>
                <measurement group_id="B3" value="60"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="12"/>
                <measurement group_id="B2" value="15"/>
                <measurement group_id="B3" value="27"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="18"/>
                <measurement group_id="B2" value="15"/>
                <measurement group_id="B3" value="33"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="17"/>
                <measurement group_id="B2" value="16"/>
                <measurement group_id="B3" value="33"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="13"/>
                <measurement group_id="B2" value="14"/>
                <measurement group_id="B3" value="27"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Uncorrected Visual Acuity (UCVA)</title>
        <description>Uncorrected Visual Acuity (UCVA) from surgery measured in logMAR. LogMAR is the “logarithm of the minimum angle of resolution”. A lower logMAR value indicates better visual acuity.</description>
        <time_frame>6 Months after surgery</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>AcrySof Toric IOL</title>
            <description>AcrySof Toric Intraocular Lens</description>
          </group>
          <group group_id="O2">
            <title>AcrySof Natural IOL</title>
            <description>AcrySof Natural Intraocular Lens</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="30"/>
                  <measurement group_id="O2" value="30"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Uncorrected Visual Acuity (UCVA)</title>
            <description>Uncorrected Visual Acuity (UCVA) from surgery measured in logMAR. LogMAR is the “logarithm of the minimum angle of resolution”. A lower logMAR value indicates better visual acuity.</description>
            <units>logMAR</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="0.06" spread="0.14"/>
                  <measurement group_id="O2" value="0.14" spread="0.11"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Questionnaire Results</title>
        <description>Results of questionnaire rating the quality of distance vision without glasses or contact lenses. Measured on a scale of 0 to 6 (0 = worst, 6 = best).</description>
        <time_frame>6 Months</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>AcrySof Toric IOL</title>
            <description>AcrySof Toric Intraocular Lens</description>
          </group>
          <group group_id="O2">
            <title>AcrySof Natural IOL</title>
            <description>AcrySof Natural Intraocular Lens</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="30"/>
                  <measurement group_id="O2" value="30"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Questionnaire Results</title>
            <description>Results of questionnaire rating the quality of distance vision without glasses or contact lenses. Measured on a scale of 0 to 6 (0 = worst, 6 = best).</description>
            <units>Units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Error</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="5.6" spread="0.7"/>
                  <measurement group_id="O2" value="4.5" spread="0.7"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>AcrySof Toric IOL</title>
          <description>AcrySof Toric Intraocular Lens</description>
        </group>
        <group group_id="E2">
          <title>AcrySof Natural IOL</title>
          <description>AcrySof Natural Intraocular Lens</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Alcon Clinical</name_or_title>
      <organization>Alcon Research, Ltd.</organization>
      <phone>888.451.3937; 817.568.6725</phone>
      <email>medinfo@alconlabs.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
